 |
|
| Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
| Reply |
|
|
Thread Tools | Display Modes |
|
|
05-28-2010, 07:20 AM
|
#1 | ||
|
|||
|
New Member
|
I am in this study and have benefited greatly from this drug. The study has been extended for another 12-18 months. I beilieve the reason is that the pool of particaipants was not large enough and the FDA required more info. It will be especially useful for PD patients with low bood pressure that drops when you stand up, etc. I suffered with dizziness, fainting, nausea and vomiting until I began this study. I am doing much better and able to function daily.
|
||
|
 Reply With Quote
|
| "Thanks for this!" says: | paula_w (05-28-2010) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Spheramine(r) phase IIB study did not meet endpoints | Parkinson's Disease Clinical Trials | |||
| 5 Phase bone scan study | Reflex Sympathetic Dystrophy (RSD and CRPS) | |||
| Successful Completion of Phase Ib Clinical Study for Myogane | ALS News & Research | |||
| Positive Results of Phase 3 Study of Fampridine-SR on walking | Multiple Sclerosis | |||
I am in Droxidopa study.
Hybrid Mode
